美国 · SEC FORM 4
NEUROONE MEDICAL TECHNOLOGIES Corp
NMTC · Nasdaq · CIK 0001500198 · Healthcare · Medical Devices
内部人信号
1 位买方 · 1 条买入交易行 · $67.0K 买入总额
为什么有这个信号？
评分构成
每条进度条表示其对当前分数的贡献；权重和公式保持不变。
哪些因素限制了当前分数？
- ⚠ Cluster breadth is moderate · 1 insider(s), not 4+
- ⚠ Purchase size is modest relative to the model scale
- ⚠ Buying conviction is reduced by concurrent selling
- ✓ 角色得分高 · 买入者中职位最高的是：Chief Business Officer
Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.
US-v1.2 按当前 180 天规则给合资格的股票买入打分。分数只表示研究的先后，不是收益预测或概率。回测没有显示美国分数越高、之后的表现越好。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
—
买方广度与集中度
Roles in the peak window: Chief Business Officer. Concentration uses priced qualifying P lines only and does not change the saved score.
信号历史
最新留档分数
- 39.0
- 38.9
- 38.8
- 38.6
- 38.5
Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
市场背景补充近期价格表现与风险信息，不影响内部人信号。
价格表现
- 1M
- -29.1%
- 3M
- -57.9%
- 6M
- -74.5%
- 12M
- -82.1%
波动率与流动性
- 波动率
- 86.8%
- Beta
- —
- 平均每日成交额
- USD 379,888
估值
- 市值
- USD 9.7M
- P/E
- —
基本面
- 利润率
- -39.6%
- ROE
- -51.0%
- 细分行业
- Medical Devices
市场数据
价格数据截至：2026-10-11 · 价格来源：OpenBB/yfinance; 成交量来自 本机价格缓存 (yfinance) · 来自 SEC 申报文件：市值, 利润率, ROE · 财年截止日：2025-09-30 · 市值 = 申报文件封面所列的已发行股数 × 最新收盘价。股数日期：2026-06-10 · Status: PASS
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 178,730
- 上期报告
- 75,782
- 日均成交量
- 150,116
- 回补天数
- 1.2
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-08-27 | Wambeke David J. | 买入 (P) | Common Stock | 33,333 | USD 2.01 | USD 66,999 | SEC 申报 ↗ |
| 2026-03-01 | Wambeke David J. | 买入 (P) | Common Stock | 1,000,000 | USD 0.67 | USD 670,000 | SEC 申报 ↗ |
| 2025-04-04 | Rosa David A | 买入 (P) | Common Stock | 100,000 | USD 0.50 | USD 50,000 | SEC 申报 ↗ |
| 2025-04-04 | McClurg Ronald W. | 买入 (P) | Common Stock | 200,000 | USD 0.50 | USD 100,000 | SEC 申报 ↗ |
| 2023-12-21 | Volker Christopher | 买入 (P) | Common Stock | 75,000 | USD 1.40 | USD 105,000 | SEC 申报 ↗ |
| 2023-09-13 | McClurg Ronald W. | 买入 (P) | Common Stock | 50,900 | USD 0.98 | USD 49,882 | SEC 申报 ↗ |
| 2022-06-15 | McClurg Ronald W. | 买入 (P) | Common Stock | 10,000 | USD 1.02 | USD 10,200 | SEC 申报 ↗ |
| 2022-06-10 | McClurg Ronald W. | 买入 (P) | Common Stock | 14,000 | USD 1.06 | USD 14,840 | SEC 申报 ↗ |
| 2022-05-24 | McClurg Ronald W. | 买入 (P) | Common Stock | 10,500 | USD 0.98 | USD 10,290 | SEC 申报 ↗ |
| 2022-05-20 | McClurg Ronald W. | 买入 (P) | Common Stock | 17,500 | USD 0.85 | USD 14,875 | SEC 申报 ↗ |
Form 4 申报证据
18 transaction lines in the latest 365-day window; 168 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-08-27 | Wambeke David J. | 买入 (P) | Common Stock | 33,333 | USD 2.01 | USD 66,999 | SEC 申报 ↗ |
| 2026-06-30 | Christianson Mark | 卖出 (S) | Common Stock | 10,000 | USD 3.18 | USD 31,800 | SEC 申报 ↗ |
| 2026-04-03 | Mills Jason Richard | 奖励／授予 (A) | Common Stock | 41,929 | USD 0.00 | USD 0 | SEC 申报 ↗ |
展开近期 Form 4 证据 (18 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-08-27 | Wambeke David J. | 买入 (P) | Common Stock | 33,333 | USD 2.01 | USD 66,999 | SEC 申报 ↗ |
| 2026-06-30 | Christianson Mark | 卖出 (S) | Common Stock | 10,000 | USD 3.18 | USD 31,800 | SEC 申报 ↗ |
| 2026-04-03 | Mills Jason Richard | 奖励／授予 (A) | Common Stock | 41,929 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-03 | MATHIESEN JEFFREY S | 奖励／授予 (A) | Common Stock | 41,929 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-03 | BUCKMAN PAUL | 奖励／授予 (A) | Common Stock | 41,929 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-03 | Andrle Edward | 奖励／授予 (A) | Common Stock | 41,929 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-13 | Christianson Mark | 卖出 (S) | Common Stock | 100 | USD 0.80 | USD 80 | SEC 申报 ↗ |
| 2026-03-12 | Christianson Mark | 卖出 (S) | Common Stock | 817 | USD 0.80 | USD 654 | SEC 申报 ↗ |
| 2026-03-11 | Christianson Mark | 卖出 (S) | Common Stock | 2,109 | USD 0.80 | USD 1,687 | SEC 申报 ↗ |
| 2026-03-10 | Christianson Mark | 卖出 (S) | Common Stock | 11,611 | USD 0.80 | USD 9,289 | SEC 申报 ↗ |
| 2026-03-01 | Wambeke David J. | 买入 (P) | Common Stock | 1,000,000 | USD 0.67 | USD 670,000 | SEC 申报 ↗ |
| 2026-02-18 | Rosa David A | 代扣税 (F) | Common Stock | 71,325 | USD 0.68 | USD 48,501 | SEC 申报 ↗ |
| 2026-02-18 | Mertens Steve | 代扣税 (F) | Common Stock | 7,376 | USD 0.68 | USD 5,016 | SEC 申报 ↗ |
| 2026-02-18 | Christianson Mark | 代扣税 (F) | Common Stock | 1,812 | USD 0.68 | USD 1,232 | SEC 申报 ↗ |
| 2025-12-31 | Rosa David A | 代扣税 (F) | Common Stock | 2,458 | USD 0.76 | USD 1,868 | SEC 申报 ↗ |
| 2025-12-31 | Mertens Steve | 代扣税 (F) | Common Stock | 906 | USD 0.76 | USD 689 | SEC 申报 ↗ |
| 2025-12-31 | Christianson Mark | 代扣税 (F) | Common Stock | 253 | USD 0.76 | USD 192 | SEC 申报 ↗ |
| 2025-12-18 | Mills Jason Richard | 奖励／授予 (A) | Common Stock | 7,758 | USD 0.00 | USD 0 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | NMTC |
| CIK | 0001500198 |
| 行业 | Healthcare |
| 细分行业 | Medical Devices Yahoo Finance |
| SEC SIC | 3841 Surgical & Medical Instruments & Apparatus |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 168 transaction lines from 2020-02-10 to 2026-08-27 10 P purchase lines · 25 S sale lines · 133 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.